News
Google News: Keryx Announces Positive Top-Line Results from Phase 3 Study ...
[BioMedReports (subscription)] - Ron Bentsur, Chief Executive Officer of Keryx, said, "We congratulate our partner, JT/Torii, on their successful Phase 3 study and we are excited by their progress. We are also encouraged about our partner's plans to file their marketing application in
Investegate |XTL Biopharm Ltd Announcements | XTL Biopharm Ltd:...
www.investegate.co.uk
Investegate announcements from XTL Biopharm Ltd, Appointment of Ron Bentsur as CEO
Keryx Biopharma To Change CEO Role From Ron Bentsur To Greg Madison
www.rttnews.com
of Chief Executive Officer from Ron Bentsur to its current Chief ...
UPDATE 1-FDA approves Keryx's kidney drug with warnings, shares fall...
www.reuters.com
year-over-year basis," Keryx CEO Ron Bentsur told Reuters.
sorted by relevance / date